Navigation Links
Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur

d responds to a certain interaction partner such as hormones, immune mediators or other
substances.
Renin: enzyme that catalyzes the formation of angiotensin I (Ang I) from its precursor angiotensinogen and thus initiates the reninangiotensin
system cascade.
Run-in period: time window during which blood pressure monitoring devices are placed at the participants by specialized staff and first
measurements begin. During this time window blood pressure values can be influenced by the general handling and the contact with the
doctor (so called “white coat effect”).
SBP: systolic blood pressure.
Small molecule drugs: low molecular weight chemical compounds. Many pharmaceutical drugs are small molecules.
Stroke: a sudden interruption in the blood supply of the brain. Most strokes are caused by an abrupt blockage of arteries leading to the
brain; others are caused by bleeding into brain tissue when a blood vessel bursts (see also intracerebral hemorrhage).
Systolic blood pressure: the highest pressure within the arterial blood stream occurring during each heart beat. “Systolic” refers to the
contraction of the heart muscle.
Therapeutic vaccine: a preparation of disease-related molecules (antigens) of foreign or self origin that is capable of activating the
immune system against such antigens with the goal to modulate disease processes.
This foregoing press release may contain forward-looking statements that include words or phrases such as “potentially”, “may”, “would”, “suggest”,
“should”, “might”, “designed”, “intend” or other similar expressions. These forward-looking statements are subject to a variety of significant
uncertainties, including scientific, business, economic and financial factors, and therefore actual results may differ significantly fro
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
2. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
3. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
5. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
6. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
7. New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension
8. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
9. King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
10. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
(Date:4/1/2015)... 1, 2015  For many businesses and industries just ... the case, having the right management software can be ... better than software solutions company TraxStar Technologies , ... the company announced the release of the newest version ... "QATrax ...
(Date:4/1/2015)... , April 1, 2015  The U.S. Food ... Sense4Baby™ wireless maternal/fetal monitoring system ... by pregnant patients to self-administer non-stress tests (NST). ... the FDA for use accompanied by medical professionals. ... European Commission in 2013 for self-administration, including the ...
(Date:4/1/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... medical paper has been published describing the positive ... with severe dry eye.  The results met key ... stated that statistically significant differences in both signs ... at various time points throughout the study.  Of ...
Breaking Medicine Technology:TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available 2AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 2AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 3AirStrip Sense4Baby System Receives FDA Clearance for Patient Self-Administration 4RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 2RegeneRx's RGN-259 Meets Key Efficacy Objectives in Phase 2 Clinical Trial in Patients with Severe Dry Eye Reported in Current Issue of Cornea 3
... Md., Dec. 19, 2011 Medical imaging has revolutionized healthcare ... injury and disease. Modern equipment and protocols ensure that ... possible amounts of radiation, while still providing accurate results ... imaging and any medical procedure must be balanced with ...
... CAMBRIDGE, Mass., Dec. 19, 2011 At universities, ... ethics review boards tasked with overseeing the protection ... to improve the quality of reviews and research ... tremendous obligation from federal regulation and face intense pressure from ...
Cached Medicine Technology:AAPM Cautions that Patients Should Not Forgo Essential Medical Imaging 2IRBNet Announces 4th Annual IRBNet Ethics in Human Research Protection Award 2IRBNet Announces 4th Annual IRBNet Ethics in Human Research Protection Award 3IRBNet Announces 4th Annual IRBNet Ethics in Human Research Protection Award 4
(Date:4/1/2015)... 2015 Like a mosaic slowly gaining ... understanding of the potential causes of rosacea. April has ... Rosacea Society (NRS) to educate the public on the ... now estimated to affect more than 16 million Americans. ... on rosacea through its patient-funded research grants program, awarding ...
(Date:4/1/2015)... April 01, 2015 IQ Formulations , ... and nutritional supplement companies in the U.S., today is commending ... and quality control standards for its herbal supplements.* GNC vowed ... chain to ensure the accuracy of labeling on its products. ... and IQ Formulations CEO Jay Cohen said: ...
(Date:4/1/2015)... MEETING, PA (PRWEB) April 01, 2015 ... assistance company and a subsidiary of West Corporation, today ... available at http://blog.healthadvocate.com and through the Health ... help healthcare consumers get, and stay, healthy. , “We’re ... contents available to the public,” said Martin Rosen, Executive ...
(Date:4/1/2015)... 01, 2015 When annoying or concerning ... days or weeks for an appointment with a dermatologist ... next day appointments haven’t been possible within dermatology. However, ... offices have noticed demand for this level of service ... how important relief or answers to dermatological issues are ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Senior Helpers ... of Home Care Provider of Choice Award by Home Care ... Award is given to home care providers who receive ... are best-in-class for quality in home care. This recognition reassures ... satisfaction and will provide you with quality, trustworthy in home ...
Breaking Medicine News(10 mins):Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Health Advocate Launches New Health and Wellness Blog 2Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2Health News:Senior Helpers of Central Texas Awarded Prestigious 2015 Senior Home Care Provider of Choice Award from Home Care Pulse 2
... with mild form of the digestive disorder have slightly higher ... -- People with milder symptoms of celiac disease face a ... study finds. , Cancer and heart disease were the main ... was higher in people who had had small-intestinal biopsies in ...
... researchers say , TUESDAY, Sept. 15 (HealthDay News) -- ... much less likely to survive than white patients, a new ... from the hospital in which black patients receive care, although ... , "We know that survival after having a cardiac arrest ...
... , , , ... Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN ... and Drug Administration (FDA) has approved the company,s supplemental biologics license application ... , , The U.S. licensed Influenza A (H1N1) ...
... , SAN FRANCISCO, Sept. 15 ... Institute for Quantitative Biomedical Research (QB3) at the University ... Discovery, Inc. (CDD) are pleased to announce the prestigious ... Annual Collaborative Drug Discovery - UCSF Community Meeting for ...
... Cowen Group, Inc. (Nasdaq: COWN ) announced today ... in the Investment Banking Group to lead the Firm,s medical technology ... report to Peter Reikes, Head of Cowen,s Health Care Investment Banking ... years of health care investment banking experience and joins Cowen most ...
... INDIANAPOLIS Indiana University School of Medicine scientists ... funded by the federal economic stimulus legislation, funding ... employment on the medical center campus. More ... Reinvestment Act awards ranging from a $1.4 million ...
Cached Medicine News:Health News:Blacks Fare Worse After Cardiac Arrest 2Health News:Blacks Fare Worse After Cardiac Arrest 3Health News:U.S. FDA Licenses Sanofi Pasteur's Pandemic Influenza Vaccine 2Health News:U.S. FDA Licenses Sanofi Pasteur's Pandemic Influenza Vaccine 3Health News:U.S. FDA Licenses Sanofi Pasteur's Pandemic Influenza Vaccine 4Health News:U.S. FDA Licenses Sanofi Pasteur's Pandemic Influenza Vaccine 5Health News:3rd Annual Collaborative Drug Discovery - UCSF Community Meeting for Catalyzing Humanitarian and Commercial Research to be Held October 1st 2Health News:3rd Annual Collaborative Drug Discovery - UCSF Community Meeting for Catalyzing Humanitarian and Commercial Research to be Held October 1st 3Health News:3rd Annual Collaborative Drug Discovery - UCSF Community Meeting for Catalyzing Humanitarian and Commercial Research to be Held October 1st 4Health News:Cowen Announces Hiring of Don Munoz to Lead Medical Technology Practice; 5th Senior-Level Addition to Cowen's Health Care Franchise in 2009 2Health News:Indiana U medical researchers boost research and jobs with stimulus legislation grants 2Health News:Indiana U medical researchers boost research and jobs with stimulus legislation grants 3Health News:Indiana U medical researchers boost research and jobs with stimulus legislation grants 4
... Hemoccult SENSA fecal occult blood tests ... medical practice as a way to ... stool specimens, an early indication of ... that annual screening with Hemoccult will ...
... The use of guaiac as ... of blood is based on ... present in guaiac to quinones, ... a blue color. If blood ...
... Luna is based on a natural human ... a woman's most fertile time, your body ... be released. At the same time, the ... your saliva. It is these salt crystals ...
... thirty years, the Hemoccult fecal occult blood test ... blood in stool specimens as an early indication ... Hemoccult products many of which were conducted ... of participants- have been published in leading medical ...
Medicine Products: